ATOX1 drives hepatocellular carcinoma progression through c-Myb and PI3K/AKT activation
Background and aims Despite advancements in diagnostic and therapeutic strategies, hepatocellular carcinoma (HCC) remains a leading cause of…
Breakthroughs in diagnosis and therapy for transthyretin amyloidosis
Transthyretin amyloidosis (ATTR) is caused by the misfolding and aggregation of the transthyretin (TTR) protein, leading to multi-organ…
New ‘dual-mode’ tracer agent enhances precision in prostate cancer procedures
A preclinical evaluation of a new ‘dual-mode’ tracer agent shows promise in not only helping surgeons image and…
New system uses ECG and blood markers for Takotsubo Syndrome
It is often mistaken for a heart attack, but Takotsubo cardiomyopathy – previously known as Broken Heart syndrome…